Hypogonadism Secondary to Hyperprolactinaemia: Successful Treatment but Adverse Consequences

Abstract

It is accepted that care must be taken in initiating testosterone replacement in hypogonadal individuals with historically low androgen levels. However less is reported about the influence of restoration of normal endogenous testosterone production on behaviour.

Here we report how the adverse sequelae of successful treatment of hypogonadism secondary to hyperprolactinaemia, manifesting as irritability and low threshold to aggression, were managed through a joint approach between psychiatrist and physician.

Key words

macroprolactinoma - testosterone - libido

• References

• 1 Finkelstein JW, Susman EJ, Chinchilli VM et al. Estrogen or testosterone increases self-reported aggressive behaviors in hypogonadal adolescents. J Clin Endocrinol Metab 1997; 82: 2433-2438
• 2 Finkelstein JW, Susman EJ, Chinchilli VM et al. Effects of Estrogen or Testosterone on Self-Reported Sexual Responses and Behaviors in Hypogonadal Adolescents. J Clin Endocrinol Metab 1998; 83: 2281-2285
• 3 O’Connor DB, Archer J, Hair WM et al. Effects of Testosterone on Mood, Aggression, and Sexual Behavior in Young Men: A Double-Blind, Placebo-Controlled, Cross-Over Study. J Clin Endocrinol Metab 2004; 89: 2837-2845
• 4 Wang C, Swerdloff RS, Iranmanesh A et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000 85. 2839-2853
• 5 Bagatell CJ, Heiman JR, Matsumoto AM et al. Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 1994; 79: 561-567
• 6 Binder EF, Schroeder ET, Wang Y et al. Testosterone and growth hormone improve body composition and muscle performance in older men. Sattler FR, Castaneda-Sceppa C. J Clin Endocrinol Metab 2009; 94: 1991-2001
• 7 Storer TW, Woodhouse L, Magliano L et al. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 2008; 56: 1991-1999
• 8 Sattler FR, Castaneda-Sceppa C, Binder EF et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab 2009; 94: 1991-2001
• 9 Testosterone for ‘late-onset hypogonadism’ in men?. DTB 2010; 48: 69-72
• 10 Calof OM, Singh AB, Lee ML et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005; 60: 1451-1457
• 11 Stanford JL, Just JJ, Gibbs M et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194-1198